Edgestream Partners L.P. Makes New Investment in Maximus, Inc. $MMS

Edgestream Partners L.P. purchased a new stake in Maximus, Inc. (NYSE:MMSFree Report) in the 1st quarter, Holdings Channel reports. The firm purchased 63,336 shares of the health services provider’s stock, valued at approximately $4,060,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Richardson Financial Services Inc. lifted its holdings in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after acquiring an additional 103 shares during the period. Farther Finance Advisors LLC grew its holdings in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares during the period. Parkside Financial Bank & Trust grew its holdings in Maximus by 13.4% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock valued at $109,000 after purchasing an additional 150 shares during the period. Blue Trust Inc. increased its position in Maximus by 14.6% during the first quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider’s stock worth $85,000 after purchasing an additional 168 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE MMS opened at $60.27 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00. The firm has a market capitalization of $3.17 billion, a P/E ratio of 9.02 and a beta of 0.60. The business’s 50-day simple moving average is $58.68 and its 200-day simple moving average is $68.71.

Maximus (NYSE:MMSGet Free Report) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the prior year, the company earned $2.01 EPS. The company’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities analysts predict that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a $0.33 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. Maximus’s dividend payout ratio is presently 19.76%.

Analysts Set New Price Targets

MMS has been the topic of a number of research analyst reports. Weiss Ratings lowered shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Finally, Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Check Out Our Latest Research Report on MMS

About Maximus

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.